Citation Impact
Citing Papers
Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
2010
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
2011
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)
2014
The effect of COVID certificates on vaccine uptake, health outcomes, and the economy
2022 StandoutNobel
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
2012
Global epidemiology and genotype distribution of the hepatitis C virus infection
2014
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Hepatocellular carcinoma
2018 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Characterization of full‐length hepatitis C virus genotype 4 sequences
2006
Sepsis: pathophysiology and clinical management
2016
Hepatocellular carcinoma
2012 Standout
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
Correlates of vaccine protection from influenza and its complications
2012
Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine
2012
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
2011
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
2016
The changing epidemiology of hepatitis C virus infection in Europe
2007
Global epidemiology of hepatitis C virus infection
2005 Standout
Epidemiology of invasive candidiasis
2010
Epidemiology and natural history of HCV infection
2013
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Near‐full genome characterization of unclassified hepatitis c virus strains relating to genotypes 1 and 4
2011
Prospective study of mother‐to‐infant transmission of hepatitis C virus: a 10‐year survey (1990–2000)
2003
Full genome sequence of three isolates of hepatitis C virus subtype 4b from Portugal
2008
Hepatitis C Virus Entry
2007 StandoutNobel
Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine
2012
Microneedles for drug and vaccine delivery
2012 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care
2018 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Immunological responses to pneumococcal vaccine in frail older people
2008
Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
2016
Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen-year prospective cohort study
2007
Hepatocellular Carcinoma
2011 Standout
Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related Cirrhosis
2009
Frailty in elderly people
2013 Standout
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Adjuvanted influenza vaccines
2012
HCV and the hepatic lipid pathway as a potential treatment target
2011
Randomized Controlled Trial of High-Dose Intradermal Versus Standard-Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients
2013
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Hepatocellular carcinoma
2022 Standout
Replication of hepatitis C virus
2007 StandoutNobel
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups
2020
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein
2009 StandoutNobel
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Complete genomic sequences for hepatitis C virus subtypes 4b, 4c, 4d, 4g, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r and 4t
2009
COVID-19 Passport as a Factor Determining the Success of National Vaccination Campaigns: Does It Work? The Case of Lithuania vs. Poland
2021
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
International trends in hepatocellular carcinoma incidence, 1978–2012
2019
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
TRANSMISSION OF HEPATITIS C VIRUS BETWEEN PARENTS AND CHILDREN
2006
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Invasive Candidiasis
2015 Standout
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
2013
Cancer treatment and survivorship statistics, 2016
2016 Standout
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5′ Untranslated Region Sequences
2007
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
A Dynamic View of Hepatitis C Virus Replication Complexes
2008 StandoutNobel
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Recent progress in the treatment and prevention of cancer‐related lymphedema
2014
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia
2011
Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein
2013 StandoutNobel
Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents
2014 StandoutNobel
Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*
2014
High Prevalence of Hepatitis C Virus Type 5 in Central France Evidenced by a Prospective Study from 1996 to 2002
2004
Works of Filippo Ansaldi being referenced
Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
2008
Cross-protection against drifted influenza viruses
2013
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy
2002
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
2009
Influenza control in the 21st century: Optimizing protection of older adults
2009
Mother‐to‐infant transmission of hepatitis C virus: Rate of infection and assessment of viral load and IgM anti‐HCV as risk factors*
2002
Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy
2005
Impact of Limited Cephalosporin Use on Prevalence of Methicillin-ResistantStaphylococcus aureusin the Intensive Care Unit
2009
Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
2014
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement
2011
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality
2014
Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients
2009
Vaccine-preventable diseases: From paediatric to adult targets
2014
MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
2010
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates
2010
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: The importance of cross-protection
2009
Effectiveness of a 23-valent Polysaccharide Vaccine in Preventing Pneumonia and Non-invasive Pneumococcal Infection in Elderly People: A Large-scale Retrospective Cohort Study
2005
Influence of body mass index, cholesterol, triglycerides and steatosis on pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C in patients transplanted for HCV and alcoholic cirrhosis.
2009
Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
2003
Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping
2000
Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer.
2009
Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey
2020
Neutralizing and Hemagglutination-Inhibiting Activities of Antibodies Elicited by the 2004-2005 Influenza Vaccine against Drifted Viruses
2006
Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults
2007
Safety and Immunogenicity of Conventional Subunit and MF59-adjuvanted Influenza Vaccines in Human Immunodeficiency Virus-1-seropositive Patients
2005
Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin’s Lymphoma Patients Treated with Rituximab-Containing Regimens
2011